Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
14.12
+0.28 (2.02%)
Aug 18, 2026, 3:58 PM EST
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 87,830 employees as of June 30, 2026. The number of employees decreased by 1,726 or -1.93% compared to the same quarter last year.
Employees
87,830
Change
-1,726
Growth
-1.93%
Revenue / Employee
$590,224
Profits / Employee
-$22,607
Market Cap
55.44B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 87,830 | -1,726 | -1.93% |
| Mar 31, 2026 | 87,757 | -3,128 | -3.44% |
| Dec 31, 2025 | 87,280 | -4,584 | -4.99% |
| Sep 30, 2025 | 88,502 | -5,743 | -6.09% |
| Jun 30, 2025 | 89,556 | -7,011 | -7.26% |
| Mar 31, 2025 | 90,885 | -7,304 | -7.44% |
| Dec 31, 2024 | 91,864 | -5,067 | -5.23% |
| Sep 30, 2024 | 94,245 | -6,628 | -6.57% |
| Jun 30, 2024 | 96,567 | -5,481 | -5.37% |
| Mar 31, 2024 | 98,189 | -3,546 | -3.49% |
| Dec 31, 2023 | 96,931 | -991 | -1.01% |
| Sep 30, 2023 | 100,873 | -1,423 | -1.39% |
| Jun 30, 2023 | 102,048 | 134 | 0.13% |
| Mar 31, 2023 | 101,735 | 982 | 0.97% |
| Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
| Sep 30, 2022 | 102,296 | 2,482 | 2.49% |
| Jun 30, 2022 | 101,914 | 2,475 | 2.49% |
| Mar 31, 2022 | 100,753 | 1,424 | 1.43% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Veradigm | 2,300 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 105 |
| Silence Therapeutics | 88 |
| Elite Pharmaceuticals | 65 |
| Vaxart | 65 |
| CytoDyn | 13 |
Bayer Aktiengesellschaft News
- 2 days ago - Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Bayer - Nasdaq
- 4 days ago - 3 Large-Cap Stocks to Watch as Pharma Recovery Takes Hold - Nasdaq
- 7 days ago - Voyageur moves to end North America’s reliance on imported contrast media - BNN Bloomberg
- 12 days ago - Missouri Court Grants Delay for Bayer’s Roundup Settlement Hearing - The Wall Street Journal
- 12 days ago - Bayer's $7.25 billion Roundup deal gets new September court date - Reuters
- 12 days ago - Bayer price target raised to EUR 61 from EUR 50 at JPMorgan - TheFly
- 13 days ago - Bayer seeks short delay to $7.25 billion Roundup settlement hearing - Reuters
- 14 days ago - Bayer Stock Jumps 3.7% as Seed Profit Tops Forecasts - GuruFocus